MNBTD
BPMC

Moody National Bank Trust Division’s Blueprint Medicines BPMC Stock Holding History

Moody National Bank Trust Division’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-63
Closed -$5K – 443
2019
Q1 		$5K Sell
63
-32
-34% -$2.37K ﹤0.01% 866
2018
Q4 		$5K Buy
+95
New +$5.77K ﹤0.01% 753

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Moody National Bank Trust Division's BPMC Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Blueprint Medicines (BPMC) in Q2 2019, closing a stake of 63 shares — an estimated $5K sold.

Moody National Bank Trust Division first reported a position in BPMC in Q4 2018 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 220 funds tracked by Wall St. Rank hold BPMC as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Blueprint Medicines position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 63 Blueprint Medicines shares in Q2 2019, an estimated $5K.
  • Moody National Bank Trust Division first reported a position in Blueprint Medicines in Q4 2018 and held it in 2 quarters.
  • Moody National Bank Trust Division's Blueprint Medicines position peaked at $5K in Q1 2019.
  • 220 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.